Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome.

MLA

Assrawi, Eman, et al. “Mosaic Variants in TNFRSF1A: An Emerging Cause of Tumour Necrosis Factor Receptor-Associated Periodic Syndrome.” Rheumatology (Oxford, England), vol. 62, no. 1, Dec. 2022, pp. 473–79. EBSCOhost, https://doi.org/10.1093/rheumatology/keac274.

APA

Assrawi, E., Louvrier, C., El Khouri, E., Delaleu, J., Copin, B., Dastot-Le Moal, F., Piterboth, W., Legendre, M., Karabina, S. A., Grateau, G., Amselem, S., & Giurgea, I. (2022). Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford, England), 62(1), 473–479. https://doi.org/10.1093/rheumatology/keac274

Chicago

Assrawi, Eman, Camille Louvrier, Elma El Khouri, Jérémie Delaleu, Bruno Copin, Florence Dastot-Le Moal, William Piterboth, et al. 2022. “Mosaic Variants in TNFRSF1A: An Emerging Cause of Tumour Necrosis Factor Receptor-Associated Periodic Syndrome.” Rheumatology (Oxford, England) 62 (1): 473–79. doi:10.1093/rheumatology/keac274.